Biofil Chemicals & Pharmaceuticals: To review, consider and approve the Standalone Unaudited Financial Results for the quarter and half year…
Biofil Chemicals & Pharmaceuticals (BIOFILCHEM) filed a disclosure titled "To review, consider and approve the Standalone Unaudited Financial Results for the quarter and half year ended on 30th September 2026 along with Limited Review Report". The company is…
What happened
Biofil Chemicals & Pharmaceuticals (BIOFILCHEM) filed a disclosure with the exchanges on 14 November 2026 at 06:46 PM titled "To review, consider and approve the Standalone Unaudited Financial Results for the quarter and half year ended on 30th September 2026 along with Limited Review Report".
Company snapshot
Biofil Chemicals & Pharmaceuticals is a micro-cap company, with a market value of about ₹51.57 crore.
The stock last traded at ₹31.69, against a 52-week range of ₹25.6–₹46.34 (31.6% below the high).
Before this filing the shares had moved +5.0% over the month and −0.3% over three months. Average daily turnover over the last 20 sessions was about ₹0.02 crore.
Promoters held 46.79% at the end of Q1 FY27.
| Quarter | Revenue | Net profit | EPS (₹) |
|---|---|---|---|
| Q1 FY26 | 6 | 2.4 | 1.48 |
| Q2 FY26 | 14 | 0.1 | 0.05 |
| Q3 FY26 | 1 | 0.1 | 0.05 |
| Q4 FY26 | 8 | 0.2 | 0.13 |
| Q1 FY27 | 12 | 0.1 | 0.07 |
What history shows
BCEIE's records show 2 previous results filings from the company since May 2026.
After those filings, the stock fell 2.3% on average the next trading day and was down 2.4% on average after five days (2 filings with price data).
Market-wide, 11,788 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 43% rising.
Past reactions describe what happened before; they are not a forecast.
| Date | Filing | Next day | 5 days |
|---|---|---|---|
| 11 Aug 2026 | Un-Audited Financial Results For The Quarter Ended 30Th June 2026 | −2.6% | −5.3% |
| 30 May 2026 | Audited Financial Result For The Financial Year Ended 31.03.2026 | −2.1% | +0.6% |
What to watch
- Management commentary, margins and order book or guidance in the investor presentation.
- 14 November 2026: Board meeting — Financial Results/Other business matters.
In the news
Recent coverage elsewhere (links open the original publisher):
Source
Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.